Serum HBV RNA levels among untreated adults with chronic hepatitis B in distinct immune phases and liver histopathology statuses
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serum HBV RNA levels among untreated adults with chronic hepatitis B in distinct immune phases and liver histopathology statuses
Authors
Keywords
-
Journal
JOURNAL OF MOLECULAR HISTOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-10-16
DOI
10.1007/s10735-023-10162-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Characteristics of HBV Novel Serum Markers across Distinct Phases in Treatment-Naïve Chronic HBV-Infected Patients
- (2022) Hao Liao et al. DISEASE MARKERS
- Significant histological disease of patients with chronic hepatitis B virus infection in the grey zone
- (2022) Jian Wang et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Effect of the change in antiviral therapy indication on identifying significant liver injury among chronic hepatitis B virus infections in the grey zone
- (2022) Shan Ren et al. Frontiers in Immunology
- Serum HBV RNA correlated with intrahepatic cccDNA more strongly than other HBV markers during peg-interferon treatment
- (2021) Xiaomei Wang et al. Virology Journal
- Distribution and clinical characteristics of patients with chronic hepatitis B virus infection in the grey zone
- (2021) Kefang Yao et al. JOURNAL OF VIRAL HEPATITIS
- Comparison of HBV RNA and Hepatitis B Core Related Antigen With Conventional HBV Markers Among Untreated Adults With Chronic Hepatitis B in North America
- (2021) Marc G. Ghany et al. HEPATOLOGY
- Antiviral Therapy for Chronic HBV Infection With Persistently Normal Alanine Aminotransferase: Controversy and Consensus
- (2021) Jing Zhou et al. Frontiers in Medicine
- Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy
- (2020) Mindie H. Nguyen et al. CLINICAL MICROBIOLOGY REVIEWS
- Factors associated with the biphasic kinetics of serum HBV RNA in patients with HBeAg-positive chronic hepatitis B treated with nucleos(t)ide analogues
- (2020) Shi Liu et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Biogenesis and molecular characteristics of serum hepatitis B virus RNA
- (2020) Sheng Shen et al. PLoS Pathogens
- Fibrosis: from mechanisms to medicines
- (2020) Neil C. Henderson et al. NATURE
- HBV RNA Profiles in Patients With Chronic Hepatitis B Under Different Disease Phases and Antiviral Therapy
- (2020) Lung‐Yi Mak et al. HEPATOLOGY
- Therapeutic strategies for hepatitis B virus infection: towards a cure
- (2019) Gregory C. Fanning et al. NATURE REVIEWS DRUG DISCOVERY
- Pre‐genomic HBV RNA and HBcrAg predict outcomes in HBeAg negative chronic hepatitis B patients suppressed on nucleos(t)ide analogue therapy
- (2019) Ivana Carey et al. HEPATOLOGY
- Anti-viral therapy can be delayed or avoided in a significant proportion of HBeAg-negative Caucasian patients in the Grey Zone
- (2018) M. Bonacci et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- When and how should we perform a biopsy for HCC in patients with liver cirrhosis in 2018? A review
- (2018) Francesco Paolo Russo et al. DIGESTIVE AND LIVER DISEASE
- HBV serum DNA and RNA levels in nucleos(t)ide analogue-treated or untreated patients during chronic and acute infection
- (2018) Emily K. Butler et al. HEPATOLOGY
- Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
- (2018) Norah A. Terrault et al. HEPATOLOGY
- Chronic Hepatitis B Infection
- (2018) Lydia S. Y. Tang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Serum HBV DNA plus RNA shows superiority in reflecting the activity of intrahepatic cccDNA in treatment-naïve HBV-infected individuals
- (2018) Hongxin Huang et al. JOURNAL OF CLINICAL VIROLOGY
- Relationship between serum HBV-RNA levels and intrahepatic viral as well as histologic activity markers in entecavir-treated patients
- (2018) Jing Wang et al. JOURNAL OF HEPATOLOGY
- Serum HBV RNA as a Predictor of Peginterferon Alfa-2a Response in Patients With HBeAg-Positive Chronic Hepatitis B
- (2018) Florian van Bömmel et al. JOURNAL OF INFECTIOUS DISEASES
- Natural history of serum HBV-RNA in chronic HBV infection
- (2018) J. Wang et al. JOURNAL OF VIRAL HEPATITIS
- New and Old Biomarkers for Diagnosis and Management of Chronic Hepatitis B Virus Infection
- (2018) Carla S. Coffin et al. GASTROENTEROLOGY
- Serum HBV RNA: a New Potential Biomarker for Chronic Hepatitis B Virus Infection
- (2018) Shi Liu et al. HEPATOLOGY
- Serum HBV pgRNA as a clinical marker for cccDNA activity
- (2017) Katja Giersch et al. JOURNAL OF HEPATOLOGY
- Reduction of covalently closed circular DNA with long-term nucleos(t)ide analogue treatment in chronic hepatitis B
- (2017) Ching-Lung Lai et al. JOURNAL OF HEPATOLOGY
- The Role of cccDNA in HBV Maintenance
- (2017) Lena Allweiss et al. Viruses-Basel
- HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B
- (2015) Michael Nassal GUT
- AASLD guidelines for treatment of chronic hepatitis B
- (2015) Norah A. Terrault et al. HEPATOLOGY
- Serum HBV RNA and HBeAg are useful markers for the safe discontinuation of nucleotide analogue treatments in chronic hepatitis B patients
- (2013) Masataka Tsuge et al. JOURNAL OF GASTROENTEROLOGY
- Liver biopsy
- (2008) Don C. Rockey et al. HEPATOLOGY
- Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease
- (2008) W. Ray Kim et al. HEPATOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started